An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for ABBVIE Inc
| Ticker | ABBV |
| FIGI | BBG0025Y4RY4 |
| CUSIP | 00287Y109 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 3203 / 45.7% |
| Percentage held by institutional investors | 78.1% |
About
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis. Wikipedia